arrow
Hongjun Song 封面图

Hongjun Song

Johns Hopkins University School of Medicine教授邮箱:shongjun@pennmedicine.upenn.edu
H指数:109
被引数:5.1万

个人简介

Research in the laboratory focuses on two core topics: (1) neural stem cell regulation and neurogenesis in the developing and adult mammalian brain and how these processes affect neural function; (2) epigenetic and epitranscriptomic mechanisms and their functions in the mammalian nervous system. The lab is also interested in addressing how dysfunction of these mechanisms may be involved in brain disorders.

教育背景

  • 1992.12

    Peking University, P.R. China B.S. Biology

  • 1995.12

    Columbia University, New York MA, M Phil Biology

  • 1998.12

    University of California at San Diego, La Jolla Ph.D. Biology

工作经历

暂无内容

荣誉奖项

暂无内容

Two-year dynamic risk stratification and adjuvant radioiodine efficacy in initial non-distant metastatic papillary thyroid carcinoma harboring TERT promoter mutations

TERT启动子突变型初始无远处转移甲状腺乳头状癌的两年动态风险分层与辅助放射性碘治疗疗效

2026-09-300
OAAI
Adult neurogenesis: New neurons, new opportunities

成年神经发生:新神经元,新机遇

2026-03-050
OAAI
Leveraging deep single-soma RNA sequencing to explore the neural basis of human somatosensation (vol 27, pg 2326, 2024)

利用深度单细胞核RNA测序探索人类体感觉的神经基础(第27卷,第2326页,2024年)

2026-03-010
OAAI
A CHOLINERGIC NEURON-TO-TUMOR CIRCUIT ENHANCES HUMAN GLIOBLASTOMA PROGRESSION VIA SYNAPTIC AND PARACRINE MECHANISMS

一个胆碱能神经元-肿瘤回路通过突触和旁分泌机制促进人类胶质母细胞瘤进展

2025-11-010
OAAI
Growth rates of patient-derived tumor organoids reflect glioblastoma patients' heterogeneity in survival

患者来源的肿瘤类器官的生长速率反映了胶质母细胞瘤患者生存的异质性

2025-11-010
OAAI
Cross-species analysis of adult hippocampal neurogenesis reveals human-specific gene expression but convergent biological processes

跨物种分析成年海马神经发生揭示了人类特异性的基因表达,但生物学过程趋同。

2025-08-110
PRE
MONOSYNAPTIC TRACING DEFINES BRAIN-WIDE CIRCUIT CONNECTIVITY OF HUMAN GLIOBLASTOMA

单突触追踪定义了人类胶质母细胞瘤的全脑电路连接

2024-11-110
PRE
PATIENT-DERIVED GLIOBLASTOMA ORGANOIDS AS REAL-TIME AVATARS FOR ASSESSING RESPONSES TO CLINICAL CAR-T CELL THERAPY

患者来源的胶质母细胞瘤类器官作为实时化身,用于评估对临床car-t细胞治疗的反应

2024-11-110
PRE